175 related articles for article (PubMed ID: 18367229)
21. Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling.
Wieczorek L; Brown BK; Delsarto Macedo C; Wesberry-Schmierer M; Ngauy V; Rosa Borges A; Michael NL; Marovich MA; Montefiori DC; Polonis VR
Virology; 2013 Dec; 447(1-2):240-8. PubMed ID: 24210120
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.
Quakkelaar ED; van Alphen FP; Boeser-Nunnink BD; van Nuenen AC; Pantophlet R; Schuitemaker H
J Virol; 2007 Aug; 81(16):8533-42. PubMed ID: 17522228
[TBL] [Abstract][Full Text] [Related]
23. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.
Haynes BF; Montefiori DC
Expert Rev Vaccines; 2006 Aug; 5(4):579-95. PubMed ID: 16989638
[TBL] [Abstract][Full Text] [Related]
24. Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China.
Nie J; Wang W; Wen Z; Song A; Hong K; Lu S; Zhong P; Xu J; Kong W; Li J; Shang H; Ling H; Ruan L; Wang Y
J Virol Methods; 2012 Nov; 185(2):267-75. PubMed ID: 22796285
[TBL] [Abstract][Full Text] [Related]
25. Neutralization of HIV by antibodies.
Prado I; Fouts TR; Dimitrov AS
Methods Mol Biol; 2009; 525():517-31, xiv. PubMed ID: 19252841
[TBL] [Abstract][Full Text] [Related]
26. Epitope-vaccines: a new strategy to induce high levels of neutralizing antibodies against HIV-1.
Xiao Y; Liao M; Lu Y; Dierich MP; Chen YH
Immunobiology; 2000 Jan; 201(3-4):323-31. PubMed ID: 10776789
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
[TBL] [Abstract][Full Text] [Related]
28. Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.
Edmonds TG; Ding H; Yuan X; Wei Q; Smith KS; Conway JA; Wieczorek L; Brown B; Polonis V; West JT; Montefiori DC; Kappes JC; Ochsenbauer C
Virology; 2010 Dec; 408(1):1-13. PubMed ID: 20863545
[TBL] [Abstract][Full Text] [Related]
29. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
30. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.
Zhou M; Kostoula I; Brill B; Panou E; Sakarellos-Daitsiotis M; Dietrich U
Vaccine; 2012 Mar; 30(11):1911-6. PubMed ID: 22269872
[TBL] [Abstract][Full Text] [Related]
31. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.
Visciano ML; Diomede L; Tagliamonte M; Tornesello ML; Asti V; Bomsel M; Buonaguro FM; Lopalco L; Buonaguro L
Vaccine; 2011 Jul; 29(31):4903-12. PubMed ID: 21596074
[TBL] [Abstract][Full Text] [Related]
32. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.
Karlsson Hedestam GB; Fouchier RA; Phogat S; Burton DR; Sodroski J; Wyatt RT
Nat Rev Microbiol; 2008 Feb; 6(2):143-55. PubMed ID: 18197170
[TBL] [Abstract][Full Text] [Related]
33. A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates.
Zolla-Pazner S; Sharpe S
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1449-58. PubMed ID: 8679288
[TBL] [Abstract][Full Text] [Related]
34. Systems serology: profiling vaccine induced humoral immunity against HIV.
Chung AW; Alter G
Retrovirology; 2017 Dec; 14(1):57. PubMed ID: 29268769
[TBL] [Abstract][Full Text] [Related]
35. Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.
Sarzotti-Kelsoe M; Daniell X; Todd CA; Bilska M; Martelli A; LaBranche C; Perez LG; Ochsenbauer C; Kappes JC; Rountree W; Denny TN; Montefiori DC
J Immunol Methods; 2014 Jul; 409():147-60. PubMed ID: 24607608
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 candidate vaccines can induce antibodies which share specificity with human monoclonal antibodies capable of neutralizing primary isolates.
Davis D
Vaccine; 1996 Mar; 14(4):353-4. PubMed ID: 8744564
[No Abstract] [Full Text] [Related]
37. New HIV plaque titration; application to the assay of neutralizing antibody.
Tsunetsugu-Yokota Y; Ohshima M; Naito A; Chermann JC; Shih J; Yoshikura H
J Virol Methods; 1993 Jan; 41(1):47-57. PubMed ID: 8432763
[TBL] [Abstract][Full Text] [Related]
38. Measuring vaccine-induced HIV neutralization: report of a workshop.
Hanson CV
AIDS Res Hum Retroviruses; 1994 Jun; 10(6):645-8. PubMed ID: 8074928
[No Abstract] [Full Text] [Related]
39. Divergent effects of cell environment on HIV entry inhibitor activity.
Rusert P; Mann A; Huber M; von Wyl V; Gunthard HF; Trkola A
AIDS; 2009 Jul; 23(11):1319-27. PubMed ID: 19579289
[TBL] [Abstract][Full Text] [Related]
40. HIV specific humoral immune response in Rio de Janeiro, Brazil. The HEC/Fiocruz AIDS Clinical Research Group.
Bongertz V; Costa CI; Guimarães ML; Soares-da-Costa MF; Grinsztejn B; Bastos FI; Pilotto JH; João Filho EC; Loureiro R; Chequer P; Telles PR; Galvão-Castro B; Morgado MG
Mem Inst Oswaldo Cruz; 1998; 93(3):391-8. PubMed ID: 9698875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
